Increasing Azithromycin Resistance in Neisseria gonorrhoeae Due to NG-MAST 12302 Clonal Spread in Canada, 2015 to 2018-Reference-Cited by-同舟云学术

Increasing Azithromycin Resistance in Neisseria gonorrhoeae Due to NG-MAST 12302 Clonal Spread in Canada, 2015 to 2018

Published:2022-03-15 Issue:3 Volume:66 Page:
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Sawatzky Pam¹,Demczuk Walter¹^ORCID,Lefebvre Brigitte²,Allen Vanessa³,Diggle Mathew⁴,Hoang Linda⁵,Van Caeseele Paul⁶,Haldane David⁷,Minion Jessica⁸,Mulvey Michael R.¹,Martin Irene¹^ORCID

Affiliation:

1. National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada

2. Laboratoire de Santé Publique du Québec, Québec City, Quebec, Canada

3. Public Health Ontario Laboratories, Toronto, Ontario, Canada

4. Provincial Laboratory for Public Health, Edmonton, Alberta, Canada

5. British Columbia Centres for Disease Control Public Health Microbiology & Reference Laboratory, Vancouver, British Columbia, Canada

6. Cadham Provincial Laboratory, Winnipeg, Manitoba, Canada

7. Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada

8. Roy Romanow Provincial Laboratory, Regina, Saskatchewan, Canada

Abstract

Azithromycin-resistant (AZIR) gonorrhea has been steadily increasing in Canada over the past decade, which is cause for alarm, as azithromycin (AZI) has been part of the combination therapy recommended by the Canadian Guidelines on Sexually Transmitted Infections (CGSTI) since 2012. Neisseria gonorrhoeae with AZI MICs ≥1 mg/L collected between 2015 and 2018 as part of the Gonococcal Antimicrobial Surveillance Program-Canada underwent antimicrobial susceptibility testing, molecular typing, and whole-genome sequencing. Regional, demographic, and clinical isolation site comparisons were made to aid in our understanding of AZI susceptibility trending.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/aac.01688-21

Reference45 articles.

1. Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016

2. Neisseria gonorrhoeae Treatment Failure and Susceptibility to Cefixime in Toronto, Canada

3. Antimicrobial resistance in Neisseria gonorrhoeae: Global surveillance and a call for international collaborative action

4. Epidemiological Trends of Antibiotic Resistant Gonorrhoea in the United Kingdom

5. Systematic review and survey of neisseria gonorrhoeae antimicrobial resistance data in the Asia Pacific, 2011 to 2016

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oxydifficidin, a potent Neisseria gonorrhoeae antibiotic due to DedA assisted uptake and ribosomal protein RplL sensitivity;2024-08-01

2. Oxydifficidin, a potent Neisseria gonorrhoeae antibiotic due to DedA assisted uptake and ribosomal protein RplL sensitivity;2024-08-01

3. Impact of mutations in the mtrR, rpdlVD and rrl genes on azithromycin resistance in Neisseria gonorrhoeae;PLOS ONE;2024-07-16

4. Oxydifficidin, a potentNeisseria gonorrhoeaeantibiotic due to DedA assisted uptake and ribosomal protein RplL sensitivity;2024-05-28

5. Target enrichment improves culture-independent detection of Neisseria gonorrhoeae and antimicrobial resistance determinants direct from clinical samples with Nanopore sequencing;Microbial Genomics;2024-03-26